|

JY231 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1

Indications

  • B Cell Acute Lymphoblastic Leukemia (B-ALL)1
  • Cancer1

Other1 trial

JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.